PCN237 IMPACT OF ORAL TARGETED THERAPY ON THE ECONOMIC BURDEN OF CLL IN CANADA
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.432
https://www.valueinhealthjournal.com/article/S1098-3015(19)32810-4/fulltext
Section Title :
Section Order :
10358
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32810-4&doi=10.1016/j.jval.2019.09.432